Global Metagenomic Sequencing Market to Reach $9.6 Billion by 2030
The global market for Metagenomic Sequencing estimated at US$2.8 Billion in the year 2022, is projected to reach a revised size of US$9.6 Billion by 2030, growing at a CAGR of 16.8% over the analysis period 2022-2030. Reagents & Consumables, one of the segments analyzed in the report, is projected to record 19.1% CAGR and reach US$4.3 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Instruments segment is readjusted to a revised 16.8% CAGR for the next 8-year period.The U.S. Market is Estimated at $752.3 Million, While China is Forecast to Grow at 24% CAGR
The Metagenomic Sequencing market in the U.S. is estimated at US$752.3 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$2.6 Billion by the year 2030 trailing a CAGR of 24% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 9.5% and 14% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 11.5% CAGR.Select Competitors (Total 33 Featured) -
- BGI Group
- DNAStar, Inc.
- Eurofins Scientific
- GENEWIZ
- Illumina, Inc.
- IntegraGen SA
- Macrogen, Inc.
- Microsynth AG
- Novogene Corporation
- NuGEN Technologies, Inc.
- Oxford Nanopore Technologies Ltd.
- PerkinElmer
- QIAGEN N.V.
- Thermo Fisher Scientific, Inc.
- Zymo Research Corporation
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its 'bumpy' reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIII. MARKET ANALYSISCANADAITALYSPAINRUSSIAREST OF EUROPESOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- BGI Group
- DNAStar, Inc.
- Eurofins Scientific
- GENEWIZ
- Illumina, Inc.
- IntegraGen SA
- Macrogen, Inc.
- Microsynth AG
- Novogene Corporation
- NuGEN Technologies, Inc.
- Oxford Nanopore Technologies Ltd.
- PerkinElmer
- QIAGEN N.V.
- Thermo Fisher Scientific, Inc.
- Zymo Research Corporation
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 89 |
Published | May 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 2.8 Billion |
Forecasted Market Value ( USD | $ 9.6 Billion |
Compound Annual Growth Rate | 16.7% |
Regions Covered | Global |